Company Financials

Dermapharm Holding SE Financials

Euro

business Dermapharm Holding SE Company Profile

Main Stock Listing

FSX: DMP

Market Capitalization €2.10 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 19.60
Forward PE 15.42
Price to Sales TTM €1.79
Price to Book MRQ €3.27
Enterprise to Revenue 2.52
Enterprise to EBITDA 11.53

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-06-30
Profit Margin 9.88%
Operating Margin 20.36%
Return on Assets TTM 6.77%
Return on Equity TTM 18.50%

Income Statement

Revenue TTM €1,174,146,048
Revenue per Share TTM €21.79
Quarterly Revenue Growth -5.40%
Gross Profit TTM €755,112,000
EBITDA €306,285,000
Net Income to Common TTM €116,032,000
Diluted EPS TTM €1.99
Quarterly Earnings Growth YoY 27.30%

Balance Sheet

Total Cash MRQ €146,576,000
Total Cash per Share MRQ €2.70
Total Debt MRQ
Total Debt to Equity MRQ 156.41
Current Ratio MRQ 2.20
Book Value per Share MRQ €11.94

Cash Flow

Operating Cash Flow TTM €206,503,008
Levered Free Cash Flow TTM €114,679,504

DMP Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 53,840,000
Float Shares 7,843,017
Avg 10 Volume 417
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 77.08%
% Held by Institutions 11.36%

Stock Price Summary

Beta 1.06
Fifty Two Week Low €31.80
Fifty Two Week High €42.15
Fifty Two Week Change -1.67%
Day 50 MA €35.74
Day 200 MA €34.98

Dividends and Splits

Forward Annual Dividend Rate €3.60
Forward Annual Dividend Yield 9.23%
Trailing Annual Dividend Rate €0.90
Trailing Annual Dividend Yield 2.31%
Payout Ratio 45.23%
Dividend Date
Ex Dividend Date 2025-06-27
Last Split Factor
Last Split Date